Actively Recruiting
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
Led by Mansoura University · Updated on 2025-09-30
120
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare combination of Solifenacin and MIrabegron in treatment of primary mono-symptomatic nocturnal enuresis in children. It will also learn about the safety of that combination. The main questions it aims to answer are: Does combination of Solifenacin and MIrabegron lower the number of wet nights? What medical problems do participants have when taking combination of Solifenacin and MIrabegron? Researchers will compare the combination to omegapress to see if the combination works better to treat primary mono-symptomatic nocturnal enuresis. Participants will: Take the combination or Omegapress every day for 3 months Visit the clinic once monthly for checkups and tests Keep a diary of their symptoms and the number of wet nights
CONDITIONS
Official Title
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary mono-symptomatic nocturnal enuresis
You will not qualify if you...
- Bowel dysfunction
- Psychiatric illness
- Respiratory sleep disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
Actively Recruiting
Research Team
A
Abdelhamid El Sayed Shahin, MBBCH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here